A method for synthesizing rabodiin R

By protecting the C-13 hydroxyl group of steviol and assembling a pyranose glycosyl donor at the C-19 position through Yamaguchi esterification, combined with Lewis acid activation and hydrolysis, the synthesis steps of ribobadiin R were simplified, solving the problems of poor flavor, low yield and harsh reaction conditions in the existing technology, and realizing efficient and green synthesis.

CN118165053BActive Publication Date: 2026-11-10GUANGZHOU BAIHUA FLAVOURS & FRAGRANCES CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410292268.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-14
Publication Date
2026-11-10
Estimated Expiration
2044-03-14

AI Technical Summary

Technical Problem

Existing methods for synthesizing riboside R suffer from problems such as significant flavor variations, complex synthesis processes, low overall yields, and stringent reaction conditions, which limit their industrial application.

Method used

The hydroxyl group at the C-13 position of steviol was protected by Yamaguchi esterification, and the carboxyl group at the C-19 position was exposed by hydrolysis. The C-13 position was then activated by Lewis acid to undergo a nucleophilic reaction with a glycosyl donor. Finally, the protecting group was removed to obtain riboside R, which simplified the synthetic steps and improved the yield.

Benefits of technology

A high yield (over 50%) and good flavor of riboside R were achieved. The synthetic route is simple and efficient, suitable for industrial production, avoids the use of highly polluting and toxic reagents, and improves product purity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118165053B_ABST
    Figure CN118165053B_ABST
Patent Text Reader

Abstract

This invention discloses a novel method for synthesizing ribobadiol R, relating to the field of chemical synthesis. The invention employs the Yamaguchi esterification method to protect the hydroxyl group at the C-13 position of steviol, avoiding the use of expensive silicon-based reagents in traditional synthesis methods. Then, a pyranose glycosyl donor is first assembled onto the exposed C-19 carboxyl group. After hydrolysis to remove the protecting group at the C-13 position, a Lewis acid is used to activate the C-13 position and assemble a trisaccharide glycosyl donor. After deprotection, ribobadiol R is obtained. The overall yield of ribobadiol R can reach over 50%, with high HPLC purity and improved flavor. The entire reaction is achieved in 5 steps, shortening the reaction process, making it simpler, more efficient, and environmentally friendly, suitable for industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of chemical synthesis, and more particularly to a method for synthesizing riboflavin R. Background Technology

[0002] Rebadiglycoside R, chemically named 13- O -[2,3-double- O [β-D-glucopyranosyl]-β-D-furanosyl]stevioside (β-D-glucopyranosyl) ester. Molecular formula: C 43 H 68 O 22 With a molecular weight of 937.02 and CAS number 1931083-53-2, it is a steviol secondary metabolite with a steviol core structure.

[0003] In 2016, McChesney et al. (McCesney, Etal. J. Nat. Prod., 2016, 79, 1468.) first reported the isolation of rebaudioside R from steviol and determined its absolute configuration. Rebaudioside R has attracted widespread attention in the food and pharmaceutical fields due to its unique physiologically active core structure and its ability to finely modulate sweetness, especially the aftertaste of traditional steviol glycosides. However, the content of naturally occurring rebaudioside R in nature is extremely low (<1%), limiting further research and application.

[0004] In 2020, Sun et al. (Sun, Etal. Org. Biomol. CHem., 2020, 18, 108) first reported the total synthetic route of ribobadiol R. Although this route employs a convergent strategy, starting with steviol, the C-13 hydroxyl group is protected by a carboxyl group, activated by a Lewis acid, and then coupled to a glycosyl donor. After deprotection of the carboxyl group, it reacts with a fully benzyl-protected bromopyranose, finally removing all benzyl protecting groups from the glycosyl donor to obtain ribobadiol R. While this route utilizes a convergent strategy to couple the C-13 hydroxyl group to the glycosyl donor, the lengthy and complex synthetic steps, especially the use of benzyl protecting groups, result in a significant difference in flavor between the synthesized ribobadiol R and the natural ribobadiol R, while also reducing atom economy and leading to a lower overall yield. Furthermore, the stringent anhydrous and anaerobic conditions and cryogenic conditions limit the industrial application of this route. Apart from this, no other synthetic routes for ribobadiol R have been reported to date.

[0005] In summary, the technologies disclosed in existing patent documents and other literature have problems such as large off-flavor differences, complex synthesis processes, low overall yields, and harsh reaction conditions. Summary of the Invention

[0006] To address the problems of significant flavor variations, complex synthesis processes, low overall yields, and stringent reaction conditions in existing technologies, the main objective of this invention is to provide a method for synthesizing ribobadiin R. This improved synthetic route yields ribobadiin R with better flavor and higher yields, shortens the reaction steps, and makes the reaction simpler, more efficient, and environmentally friendly, suitable for industrial production. Furthermore, this invention is the first to utilize the Yamaguchi esterification method, expanding the application scope and suitable substrates of this type of reaction and providing a new approach for the synthesis of ribobadiin series.

[0007] To achieve the above objectives, the present invention adopts the following technical solution: A method for synthesizing rabodiin R, comprising the following steps: S1. In triethylamine, with DMAP as a catalyst, 2,4,6-trichlorobenzoyl chloride is added dropwise to esterify steviol with an organic acid, generating an esterification group PG1 at the C-13 position of steviol, to give compound 1. ; S2. Compound 1 and compound 2 are subjected to a nucleophilic reaction to obtain compound 3, wherein compound 2 is a pyranose with a halogenated C-OH1 position and the remaining C-OH positions protected by a hydroxyl protecting group PG2. ; S3. Under mild conditions, the esterification group PG1 at the C-13 position of compound 4 is hydrolyzed to obtain compound 4 with an in-situ hydroxyl group. ; The hydroxyl group at the C-13 position of compound 4 (S4) is activated by a Lewis acid to form an oxonium ion, which then undergoes a nucleophilic reaction with a glycosyl donor to give compound 5. ; S5. Remove all protecting groups from compound 5 to obtain the target product, bourediidine R. .

[0008] The chemical synthesis principle of riboboroside R is based on the Yamaguchi esterification reaction, also known as Yamaguchi lactone esterification. In a typical Yamaguchi esterification reaction, 2,4,6-trichlorobenzoyl chloride reacts with a carboxylic acid substrate to generate a mixed anhydride, which activates the carboxylic acid. Under the catalysis of DMAP esterification, it then reacts smoothly with an alcohol reagent to form an ester, which is particularly effective for the formation of macrocyclic lactones. In the synthetic method of this application, an organic acid is added to steviol, along with triethylamine and the catalyst DMAP. 2,4,6-trichlorobenzoyl chloride is then added dropwise to activate the added organic acid, which then reacts with the hydroxyl group at the C-13 position of steviol to form a protecting group. The carboxyl group at the C-19 position of steviol does not participate in this esterification reaction and is thus exposed. Subsequently, a hydroxyl-protected glycosyl donor (compound 2) was first attached to the C-19 position of steviol. Then, the esterification protecting group at the C-13 position was removed via hydrolysis, exposing the hydroxyl group at C-13. This hydroxyl group was then activated by a Lewis acid to form an oxonium ion, which underwent a nucleophilic reaction with the hydroxyl-protected glycosyl donor (compound 6). Finally, the protecting group was removed to yield the target product, Boredil Glycoside R.

[0009] Optionally, in step S1, the organic acid is p-toluenesulfonic acid, and compound 1 is: .

[0010] Further, in step S1, the reaction temperature is from room temperature to 0°C, and the molar ratio of steviol, p-toluenesulfonic acid, triethylamine, and DMAP is 1~1.05:1.25~1.5:3.05~3.2:1~1.05. Preferably, the molar ratio of steviol, p-toluenesulfonic acid, triethylamine, and DMAP is 1:1.5:3.2:1. Specifically, steviol, p-toluenesulfonic acid, triethylamine, and DMAP are dissolved in tetrahydrofuran, and then 2,4,6-trichlorobenzoyl chloride is added dropwise. After completion, the reaction is carried out at the same temperature for 2.5 hours. When TLC monitoring shows that steviol has completely disappeared, compound 1 is generated. After the reaction, the reaction system is quenched, extracted, and subjected to aqueous phase extraction. The organic phases are combined, washed, dried, filtered, concentrated under reduced pressure, and purified by column chromatography to obtain compound 1.

[0011] Optionally, in step S2, compound 2 is a pyranose with a brominated C-1 position and the remaining C-OH positions protected by acetyl groups. .

[0012] Further, in step S2, compound 1 is dissolved in a solvent, and potassium carbonate and tetrabutylammonium bromide are added sequentially. After the addition is complete, the mixture is stirred at the same temperature. Then, compound 2 is added, and the reaction temperature is from room temperature to 70°C. The molar ratio of compound 1, potassium carbonate, tetrabutylammonium bromide, and compound 2 is 1~1.05; 3~3.05: 2~2.05: 2~2.5. Preferably, the molar ratio of compound 1, potassium carbonate, tetrabutylammonium bromide, and compound 2 is 1:3:2:2. Specifically, compound 1 is dissolved in a solvent of mixed chloroform and water. Potassium carbonate and tetrabutylammonium bromide are added sequentially to the reaction solution at room temperature with stirring. After the addition is complete, the mixture is stirred at the same temperature for 0.5 hours. Compound 2 is then added to the reaction solution, and the temperature is raised to 45°C and the reaction is allowed to proceed overnight. TLC monitoring shows that compound 1 has completely disappeared, resulting in compound 3. After the reaction, compound 3 is obtained by dilution, washing, drying, filtration, vacuum concentration, and column chromatography purification.

[0013] Optionally, the hydroxyl protecting group of compound 1 is the same as that of the glycosyl donor; compound 1 is a halopyranose protected by an acetyl group. ; The glycosyl donor is compound 6. ; Compound 5 is: .

[0014] Further, in step S3, compound 3 is dissolved in a solvent, a base is added, and the reaction temperature is 50 to 80°C; the molar ratio of compound 3 to the base is 1:1.35~1.5, and the base is triethylamine or DBU. Preferably, the base is triethylamine. Specifically, compound 3 is dissolved in a mixed solvent of tetrahydrofuran and water, triethylamine is added to the reaction solution, the temperature is raised to 50 to 80°C, and the reaction is carried out for 6 hours. When TLC monitoring shows that compound 3 has completely disappeared, compound 4 is generated. After the reaction, compound 4 is purified by extraction, filtration, and vacuum concentration, i.e., column chromatography.

[0015] Further, in step S4, the reaction temperature is -40℃ to 0℃; the Lewis acid is one of TMSOTf, BF3·Et2O, and TBDMSOTf; the molar ratio of compound 4, Lewis acid, and compound 6 is 1~1.05:2~2.1:1~1.05. Preferably, the Lewis acid is TMSOTf. Specifically, compound 4, compound 6, and activated 4Å molecular sieve (100 mg) are dissolved in dry dichloromethane sequentially. After stirring at room temperature, the suspension is extracted and cooled to -40℃ to 0℃. After cooling, the Lewis acid is added, and the reaction is carried out at the same temperature for 2 hours. When TLC monitoring shows that compound 4 has completely disappeared, compound 5 is generated. After the reaction, compound 5 is obtained by quenching, filtration, concentration, and column chromatography purification.

[0016] Furthermore, the R group of compound 6 is an acetyl group or a 2,2-dimethyl-2-(o-nitrophenyl)acetyl group.

[0017] Optionally, in step S5, the deprotection reaction temperature is 0°C to room temperature. For compounds 5 whose protecting groups are all acetyl groups, compounds 5 and the palladium-on-carbon catalyst can be dissolved in dry tetrahydrofuran and freshly prepared methanol, then hydrogen gas is introduced, and the reaction is carried out at room temperature. Once TLC monitoring shows complete disappearance of compound 5, the acetyl protection is removed. For compounds 5 whose protecting groups include acetyl and DMNPA groups, compounds 5, zinc powder, copper sulfate, and acetic acid can be added sequentially to a mixed solvent of 1,4-dioxane and water, and the reaction is carried out at room temperature. Once TLC monitoring shows compound 5 for 5 hours, the DMNPA group is removed. After completion, the acetyl groups are then removed using the method described above.

[0018] Compared with the prior art, the beneficial effects of the present invention are as follows: (1) This invention uses the Yamaguchi esterification method to protect the hydroxyl group at the C-13 position of stevia alcohol. Then, a pyranose glycosyl donor is first assembled on the exposed C-19 carboxyl group. After hydrolysis to remove the protecting group at the C-13 position, the C-13 position is activated by Lewis acid and a trisaccharide glycosyl donor is assembled. After removing the protecting group, ribobadiin R is obtained. The overall yield of ribobadiin R can reach more than 50%, with high HPLC purity and better flavor. The whole process is a 5-step reaction, which shortens the reaction steps, is simpler, more efficient and green and low carbon, and is suitable for industrial production.

[0019] (2) In the Yamaguchi esterification method of the present invention, an organic acid with a sulfonic acid group is used, which makes it easier to remove the protecting group through hydrolysis reaction. The hydrolysis reaction conditions are milder and suitable for industrial production.

[0020] (3) In this invention, the hydroxyl group at the C-13 position is activated by a Lewis acid to form an oxonium ion, which undergoes a nucleophilic reaction with the glycosyl donor. The protecting group has a good protective effect and is suitable for industrial production.

[0021] (4) In this invention, compound 2 and compound 6 are glycosyl donors at the C-13 and C-19 positions of riboside R, respectively. The hydroxyl groups on compound 2 and compound 6 are protected by acetyl groups. The protecting group can be removed in one step after the reaction, avoiding the cumbersome steps of traditional synthesis methods, avoiding the safety and environmental impact caused by highly polluting and highly toxic reagents, simplifying the post-processing procedure, improving the purity of the product, and making the synthesis route simple and efficient.

[0022] (5) Through comparative research on the protecting groups on the glycosyl donor, the present invention develops a glycosyl donor with high stereoselectivity, which can prepare a single configuration of riboside R.

[0023] The invention will now be further described with reference to the accompanying drawings. Attached Figure Description

[0024] Figure 1 The compound synthesized by the method for synthesizing rabodiin R according to the present invention 1 H-NMR spectrum; Figure 2 The compound synthesized by the method for synthesizing rabodiin R according to the present invention 13 C-NMR spectrum. Detailed Implementation

[0025] To better illustrate the objectives, technical solutions, and advantages of the present invention, the specific embodiments of the present invention will be described in further detail below with reference to the accompanying drawings and examples. The following examples are for illustrative purposes only and are not intended to limit the scope of the invention.

[0026] Name description: 1) Steviol, also known as stevioside, has the CAS number 471-80-7.

[0027] 2) p-Toluenesulfonic acid, also known as PTSA, has the CAS number 104-15-4.

[0028] 3) Triethylamine, also known as Et3N, has the CAS number 121-44-8.

[0029] 4) DMAP, also known as 4-Dimethylaminopyridine, has the CAS number 1122-58-3.

[0030] 5) Tetrahydrofuran, also known as THF, has the CAS number 109-99-9.

[0031] 6) 2,4,6-Trichlorobenzoyl chloride, with the English name 2,4,6-Trichlorobenzoyl Chloride and CAS number 4136-95-2.

[0032] 7) Ethyl acetate, also known as EtOAc, has the CAS number 141-78-6.

[0033] 8) Chloroform, also known as Trichloromethane, is also called CHCl3 and has the CAS number 67-66-3.

[0034] 9) Potassium carbonate, also known as K2CO3, has the CAS number 584-08-7.

[0035] 10) Tetrabutylammonium bromide, CAS number 1643-19-2.

[0036] 11) DBU, also known as 1,8-diazobisspirocyclic[5.4.0]undecyl-7-ene, CAS number 6674-22-2.

[0037] 12) TMSOTf, whose English name is Trimethylsilyl trifluoromethanesulfonate, is also known as trimethylsilyl trifluoromethanesulfonate, and its CAS number is 27607-77-8.

[0038] 13) BF3·Et2O, also known as Boron trifluoride etherate, has the CAS number 109-63-7.

[0039] 14) TBDMSOTf, whose English name is Trifluoromethanesulfonic acid tert-butyldimethylsilyl ester, is also known as tert-butyldimethylsilyl trifluoromethanesulfonate, and its CAS number is 69739-34-0.

[0040] 15) DMNPA, also known as 2,2-Dimethyl-2-(ortho-nitrophenyl)acetyl, is also called 2,2-dimethyl-2-(ortho-nitrophenyl)acetyl.

[0041] 16) Acetyl, also known as Ac.

[0042] 17) Palladium on carbon catalyst, also known as CH4Pd.

[0043] 18) 1,4-Dioxane, with the English name p-Dioxane and CAS number 123-91-1.

[0044] Example 1 The method for synthesizing rabodiin R according to an embodiment of the present invention includes the following steps: S1. Stevia (0.281 g, 0.833 mmol), p-toluenesulfonic acid (0.213 g, 1.24 mmol), triethylamine (0.37 ml, 2.65 mmol), and DMAP (0.108 g, 0.833 mmol) were dissolved in tetrahydrofuran (2.0 ml). 2,4,6-trichlorobenzoyl chloride (0.19 ml, 1.24 mmol) was added dropwise at 0 °C. After the addition was complete, the reaction was allowed to proceed at the same temperature for 2.5 hours. TLC (thin-layer chromatography) was used to monitor the complete disappearance of steviol, yielding compound 1.

[0045]

[0046] After the reaction was complete, step S1 also included the extraction of compound 1. Specifically, the reaction system was first quenched with saturated sodium bicarbonate (30 ml) to prevent excess reaction, and then extracted with ethyl acetate (30 ml). The aqueous phase was extracted three times with ethyl acetate (25 ml x 3). The organic phases were combined, washed successively with saturated ammonium chloride and saturated sodium chloride, dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure, and then purified by column chromatography (EA:PE = 1:15) to obtain a colorless oily compound 1 (0.352 g, yield 87%, HPLC purity 99.87%). HR-ESI-MS m / z for C 28 H 38 O5SNa[M+Na] + calcd509.2440,found509.2443.

[0047] S2. Compound 1 (29.4 mg, 0.061 mmol) obtained in step 1 was dissolved in a mixed solvent of chloroform and water (3 ml, V:V = 1:1). Potassium carbonate (25.3 mg, 0.18 mmol) and tetrabutylammonium bromide (39.4 mg, 0.122 mmol) were added sequentially to the reaction solution at room temperature with stirring. After the addition was complete, the mixture was stirred at the same temperature for 0.5 hours. After completion, compound 2 (50.16 mg, 0.122 mmol), i.e., the fully acetyl-protected bromopyranose, was added to the reaction solution. After the addition was complete, the temperature was raised to 45°C and the reaction was allowed to proceed overnight. TLC monitoring showed that compound 1 had completely disappeared, yielding compound 3.

[0048]

[0049] After the reaction was complete, step S2 also included the extraction of compound 3. Specifically, ethyl acetate (30 ml) was added for dilution. The diluted solution was washed successively with water and saturated sodium chloride. After completion, the solution was dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure, and purified by column chromatography (EA:PE = 1:8) to finally obtain a colorless, foamy compound 3 (42.33 mg, yield 85%, HPLC purity 99.36%). HR-ESI-MS m / z for C 42 H 56 O 14 SNa[M+Na] + calcd 839.3393, found839.3400.

[0050] S3. Compound 3 (8.98 mg, 0.011 mmol) obtained in step S2 was dissolved in a mixed solvent of tetrahydrofuran and water (0.5 ml, V:V = 1:1). Triethylamine (2.09 mg, 0.015 mmol) was added to the reaction solution at room temperature, the temperature was raised to 65 °C, and the reaction was carried out for 6 hours. When TLC monitoring showed that compound 3 had completely disappeared, compound 4 was generated.

[0051]

[0052] After the reaction is complete, step S3 also includes the extraction of compound 4. Ethyl acetate (25 ml x 3) is added to the reaction solution for extraction. After extraction, the extract is dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure, and finally purified by column chromatography (EA:PE = 1:4) to obtain a colorless oily compound 4.

[0053] S4. Under a nitrogen atmosphere, compound 4 (6.62 mg, 0.01 mmol), compound 6a, and activated 4Å molecular sieve (100 mg) obtained in step S3 were dissolved sequentially in dry dichloromethane (2.5 ml). The R group of compound 6a is an acetyl group. After stirring at room temperature for 10 minutes, the suspension was extracted and cooled to -40°C. After cooling, TMSOTf (0.2 μL, 0.02 mmol) was added, and the mixture was reacted at the same temperature for 2 hours. TLC monitoring showed complete disappearance of compound 4, yielding compound 5a.

[0054]

[0055] After the reaction was complete, step S3 also included the extraction of compound 5a. Specifically, triethylamine (0.5 ml) was added to the reaction solution for quenching, the molecular sieve was removed by filtration, the filtrate was concentrated, and finally purified by column chromatography (EA:PE=1; 10) to obtain compound 5a as a white solid (14.13 mg, yield 93%, HPLC purity 99.97%). HR-ESI-MS m / z for C 70 H 96 O 35 Na[M+Na] + calcd 1519.5723, found 1519.5720.

[0056] In another case, using the same method, compound 6a was replaced by compound 6b. The R group of compound 6b is a DMNPA group (DMNPA is 2,2-dimethyl-2-(o-nitrophenyl)acetyl). After step S4, compound 5b is generated with a yield of 90% and an HPLC purity of 99.90%. HR-ESI-MS m / z for C 78 H 103 O 36 NNa[M+Na] + calcd 1652.6200, found 1652.6231.

[0057] S5. Compound 5a (149.6 mg, 0.1 mmol) obtained in step S4 and palladium catalyst on carbon (35 mg) with an effective content of 10% were dissolved in dry tetrahydrofuran (3 ml) and freshly prepared methanol (30 ml). Hydrogen gas was then introduced, and the reaction was carried out at room temperature for 2 h. When TLC monitoring showed that compound 5a had completely disappeared, the acetyl group was removed, and ribobadiol R was generated.

[0058]

[0059] After the reaction is complete, step S3 also includes the extraction of ribobandiside R. Specifically, the reaction solution is filtered, the filtrate is concentrated, and then purified by column chromatography (EtOH:PE = 1:4) to obtain ribobandiside R as a white solid (yield 86%, HPLC purity 99.97%). [α] D 25 =-30.3 (c 0.2, CH3OH); 1 H-NMR (400MHz, pyridine-d5) δ6.14 (d, J=8.0Hz, 1H), 5.58 (s, 1H), 5.53 (d, J=7.6Hz, 1H), 5.32 (d, J=7.6Hz, 1H), 4.99 (s, 1H), 4.94 (d, J=7 .2Hz, 1H), 4.56(dd, J=11.6, 2.4Hz, 1H), 4.49(dd, J=11.6, 2.8Hz, 1H), 4.42(dd, J=12.0, 2.4Hz, 1H), 4.36-4.31(m, 2H), 4.29-4.16(m , 7H), 4.15-3.87 (m, 9H), 3.45 (dd, J=11.6, 9.6Hz, 1H), 2.55 (d, J=11.2Hz, 1H), 2.38 (t, J=12.4Hz, 2H), 2.22-1.84 (m, 6H), 1.75-1.6 1(m, 4H), 1.43-1.30(m, 3H), 1.25(s, 3H), 1.23(s, 3H), 1.02(d, J=11.6Hz, 2H), 0.89(d, J=6.8Hz, 1H), 0.73(dd, J=14.4, 10.4Hz, 1H); 13 C-NMR (101 MHz, pyridine-d5) δ177.3, 154.1, 105.4, 105.1, 105.0, 98.7, 96.3, 87.9, 87.2, 80.7, 79.7, 79.3, 79.0, 78.9(2C), 78.576.4, 75.8, 74.4, 72.4, 72.1 ,71.3,70.2,66.4,63.6,62.9,62.5,57.8,54.7,50.1,48.5,44.7,44.4,4 2.7, 42.2, 41.1, 40.2, 38.9, 38.4, 29.0, 22.6, 20.9, 19.9, 16.1; HR-ESI-MS m / zcalcd for C 43 H 72 NO 22 [M+NH4] + 954.4540, found 954.4556.

[0060] In another case, when compound 6a is replaced by compound 6b, step S5 includes: Compound 5b obtained in step S4 (242.8 mg, 0.15 mmol), zinc powder (97.6 mg, 1.5 mmol), copper sulfate (23.8 mg, 0.15 mmol), and acetic acid (42.7 μL, 0.75 mmol) were sequentially added to a mixed solvent of 1,4-dioxane and water (24 mL, V / V = 1:1), and reacted at room temperature for 1 hour. The removal of the DMNPA group was completed after TLC monitoring showed complete disappearance of compound 5b. Further, the mixture was filtered, and the filtrate was extracted with ethyl acetate (50 mL x 3). The organic layer was washed sequentially with saturated sodium bicarbonate and saturated sodium chloride, dried over anhydrous sodium sulfate, and concentrated under reduced pressure.

[0061]

[0062] After completion, the intermediate (145.5 mg, 0.1 mmol) and a 10% palladium catalyst on carbon were dissolved in dry tetrahydrofuran (3 ml) and freshly prepared methanol (30 ml), and then hydrogen gas was introduced. The reaction was carried out at room temperature for 2 hours. TLC monitoring showed complete disappearance of the intermediate, indicating the removal of the acetyl group, yielding ribobandi glycoside R (yield 86%, HPLC purity 99.97%). [α] 25 D =-30.3 (c0.2, CH3OH); 1 H-NMR (400MHz, pyridine-d5) δ6.14 (d, J=8.0Hz, 1H), 5.58 (s, 1H), 5.53 (d, J=7.6Hz, 1H), 5.32 (d, J=7.6Hz, 1H), 4.99 (s, 1H), 4.94 (d, J=7 .2Hz, 1H), 4.56(dd, J=11.6, 2.4Hz, 1H), 4.49(dd, J=11.6, 2.8Hz, 1H), 4.42(dd, J=12.0, 2.4Hz, 1H), 4.36-4.31(m, 2H), 4.29-4.16(m , 7H), 4.15-3.87 (m, 9H), 3.45 (dd, J=11.6, 9.6Hz, 1H), 2.55 (d, J=11.2Hz, 1H), 2.38 (t, J=12.4Hz, 2H), 2.22-1.84 (m, 6H), 1.75-1.6 1(m, 4H), 1.43-1.30(m, 3H), 1.25(s, 3H), 1.23(s, 3H), 1.02(d, J=11.6Hz, 2H), 0.89(d, J=6.8Hz, 1H), 0.73(dd, J=14.4, 10.4Hz, 1H);13 C-NMR (101MHz, pyridine-d5) δ177.3, 154.1, 105.4, 105.1, 105.0, 98.7, 96. 3, 87.9, 87.2, 80.7, 79.7, 79.3, 79.0, 78.9(2C), 78.576.4, 75.8, 74.4, 72.4, 72.1, 71.3, 70.2, 66.4, 63.6, 62.9, 62.5, 57.8, 54.7, 50.1, 48.5, 44.7, 44.4 , 42.7, 42.2, 41.1, 40.2, 38.9, 38.4, 29.0, 22.6, 20.9, 19.9, 16.1; HR-ESI-MS m / z calcd for C 43 H 72 NO 22 [M+NH4] + 954.4540, found 954.4556.

[0063] Example 2 The method for synthesizing rabodiin R according to an embodiment of the present invention includes the following steps: S1. Stevia (0.281 g, 0.833 mmol), p-toluenesulfonic acid (0.213 g, 1.24 mmol), triethylamine (0.37 ml, 2.65 mmol), and DMAP (0.108 g, 0.833 mmol) were dissolved in tetrahydrofuran (2.0 ml). 2,4,6-trichlorobenzoyl chloride (0.19 ml, 1.24 mmol) was added dropwise at room temperature. After the addition was complete, the reaction was allowed to proceed at the same temperature for 2.5 hours. TLC monitoring showed complete disappearance of steviol, yielding compound 1.

[0064] Similar to Example 1, step S1 involved quenching the reaction system, extracting the reaction system, extracting with aqueous phase, combining the organic phases, washing, drying, filtering, concentrating under reduced pressure, and extracting compound 1 by column chromatography (EA:PE = 1:15). Finally, 0.295 g of colorless oily compound 1 was obtained, with a yield of 73% and an HPLC purity of 98.97%. HR-ESI-MS m / z for C 28 H 38 O5SNa[M+Na]+calcd 509.2440, found 509.2443.

[0065] S2. Compound 1 (29.4 mg, 0.061 mmol) was dissolved in a mixture of chloroform and water (3 ml, V:V = 1:1). Potassium carbonate (25.3 mg, 0.18 mmol) and tetrabutylammonium bromide (39.4 mg, 0.122 mmol) were added sequentially to the reaction solution at room temperature with stirring. After the additions were complete, the mixture was stirred at the same temperature for 0.5 hours. After this, compound 2 (50.16 mg, 0.122 mmol), i.e., the fully acetyl-protected bromopyranose, was added to the reaction solution. After the additions were complete, the temperature was raised to 45°C and the reaction was allowed to proceed overnight. TLC monitoring showed that compound 1 had completely disappeared, yielding compound 3.

[0066] Similar to Example 1, step S2 involved dilution, washing with water and sodium chloride, drying, filtration, concentration under reduced pressure, and purification by column chromatography (EA:PE = 1:8). Finally, a colorless, foamy compound 3, 42.33 mg, was obtained in 85% yield with an HPLC purity of 99.36%. HR-ESI-MS m / z for C 42 H 56 O 14 SNa[M+Na] + calcd 839.3393, found 839.3400.

[0067] S3. Compound 3 (8.98 mg, 0.011 mmol) was dissolved in a mixed solvent of tetrahydrofuran and water (0.5 ml, V:V = 1:1). Triethylamine (2.09 mg, 0.015 mmol) was added to the reaction solution at room temperature, the temperature was raised to 65 °C, and the reaction was carried out for 6 hours. When TLC monitoring showed that compound 3 had completely disappeared, compound 4 was formed.

[0068] Similar to Example 1, step S3 involved extraction, drying, filtration, reduced pressure concentration, and column chromatography (EA:PE = 1:4) to purify the compound, finally yielding 4,6.48 mg of a colorless oil, with a yield of 89% and an HPLC purity of 99.93%. HR-ESI-MS m / z for C35H50O12Na[M+Na]+ calcd 685.3023, found 685.3020.

[0069] S4. Under a nitrogen atmosphere, compound 4 (6.62 mg, 0.01 mmol), compound 6a (9.97 mg, 0.01 mmol), and activated 4Å molecular sieve (100 mg) were dissolved sequentially in dry dichloromethane (2.5 ml). The R group of compound 6a is an acetyl group. After stirring at room temperature for 10 minutes, the suspension was extracted and cooled to -40°C. After cooling, TMSOTf (0.2 μL, 0.02 mmol) was added, and the mixture was reacted at the same temperature for 2 hours. When TLC monitoring showed complete disappearance of compound 4, compound 5a was generated. Following steps similar to those in Example 1, the compound 5a was purified by quenching, filtration of the molecular sieve, and concentration column chromatography (EA:PE=1; 10) to obtain a white solid, compound 5a, 14.13 mg, yield 93%, HPLC purity 99.97%. HR-ESI-MS m / z for C70H96O35Na[M+Na]+calcd 1519.5723, found 1519.5720.

[0070] S5. Compound 5a (149.6 mg, 0.1 mmol) and palladium on carbon catalyst (35 mg) with an active ingredient content of 10% were dissolved in dry tetrahydrofuran (3 ml) and freshly prepared methanol (30 ml). Hydrogen gas was then introduced, and the reaction was carried out at room temperature for 2 h. When TLC monitoring showed complete disappearance of compound 5a, the acetyl group was removed, yielding ribobadiin R. Following a similar procedure to Example 1, the reaction solution was filtered, the filtrate was concentrated, and purified by column chromatography (EtOH:PE = 1:4) to obtain ribobadiin R with a yield of 86% and an HPLC purity of 99.97%. [α] D 25 =-30.3 (c 0.2, CH3OH); 1H-NMR (400MHz, pyridine-d5) δ6.14 (d, J=8.0Hz, 1H), 5.58 (s, 1H), 5.53 (d, J=7.6Hz, 1H), 5.32 (d, J=7.6Hz, 1H), 4.99 (s, 1H), 4.94 (d, J=7 .2Hz, 1H), 4.56(dd, J=11.6, 2.4Hz, 1H), 4.49(dd, J=11.6, 2.8Hz, 1H), 4.42(dd, J=12.0, 2.4Hz, 1H), 4.36-4.31(m, 2H), 4.29-4.16(m , 7H), 4.15-3.87 (m, 9H), 3.45 (dd, J=11.6, 9.6Hz, 1H), 2.55 (d, J=11.2Hz, 1H), 2.38 (t, J=12.4Hz, 2H), 2.22-1.84 (m, 6H), 1.75-1.6 1(m, 4H), 1.43-1.30(m, 3H), 1.25(s, 3H), 1.23(s, 3H), 1.02(d, J=11.6Hz, 2H), 0.89(d, J=6.8Hz, 1H), 0.73(dd, J=14.4, 10.4Hz, 1H); 13 C-NMR (101 MHz, pyridine-d5) δ177.3, 154.1, 105.4, 105.1, 105.0, 98.7, 96.3, 87.9, 87.2, 80.7, 79.7, 79.3, 79.0, 78.9(2C), 78.576.4, 75.8, 74.4, 72.4, 72.1 ,71.3,70.2,66.4,63.6,62.9,62.5,57.8,54.7,50.1,48.5,44.7,44.4,4 2.7, 42.2, 41.1, 40.2, 38.9, 38.4, 29.0, 22.6, 20.9, 19.9, 16.1; HR-ESI-MS m / zcalcd for C 43 H 72 NO 22 [M+NH4] + 954.4540, found 954.4556.

[0071] In another case, compound 6a was replaced by compound 6b. The R group of compound 6b is a DMNPA group. Following the same procedure in step S4, compound 6b was obtained in 90% yield with HPLC purity of 99.90%. HR-ESI-MS m / z for C 78 H 103 O 36 NNa[M+Na]+ calcd 1652.6200, found 1652.6231.

[0072] In the case where compound 6a is replaced by compound 6b, step S5 involves: adding compound 5b (242.8 mg, 0.15 mmol) obtained in step S4, zinc powder (97.6 mg, 1.5 mmol), copper sulfate (23.8 mg, 0.15 mmol), and acetic acid (42.7 μL, 0.75 mmol) sequentially to a mixed solvent of 1,4-dioxane and water (24 ml, V / V = 1:1), and reacting at room temperature for 1 hour. Once compound 5b has completely disappeared as monitored by TLC, the removal of the DMNPA group is complete. The mixture is then filtered, extracted, washed, dried, and concentrated under reduced pressure to generate an intermediate. After completion, the intermediate (145.5 mg, 0.1 mmol) and a 10% palladium-on-carbon catalyst are dissolved in dry tetrahydrofuran (3 ml) and freshly prepared methanol (30 ml), and hydrogen gas is introduced, reacting at room temperature for 2 hours. After TLC monitoring showed complete disappearance of the intermediate, the acetyl group was removed, yielding ribobandi glycoside R (yield 86%, HPLC purity 99.97%). [α] 25 D =-30.3 (c0.2, CH3OH); 1 H-NMR (400MHz, pyridine-d5) δ6.14 (d, J=8.0Hz, 1H), 5.58 (s, 1H), 5.53 (d, J=7.6Hz, 1H), 5.32 (d, J=7.6Hz, 1H), 4.99 (s, 1H), 4.94 (d, J=7 .2Hz, 1H), 4.56(dd, J=11.6, 2.4Hz, 1H), 4.49(dd, J=11.6, 2.8Hz, 1H), 4.42(dd, J=12.0, 2.4Hz, 1H), 4.36-4.31(m, 2H), 4.29-4.16(m , 7H), 4.15-3.87 (m, 9H), 3.45 (dd, J=11.6, 9.6Hz, 1H), 2.55 (d, J=11.2Hz, 1H), 2.38 (t, J=12.4Hz, 2H), 2.22-1.84 (m, 6H), 1.75-1.6 1(m, 4H), 1.43-1.30(m, 3H), 1.25(s, 3H), 1.23(s, 3H), 1.02(d, J=11.6Hz, 2H), 0.89(d, J=6.8Hz, 1H), 0.73(dd, J=14.4, 10.4Hz, 1H); 13C-NMR (101 MHz, pyridine-d5) δ177.3, 154.1, 105.4, 105.1, 105.0, 98.7, 96.3, 87.9, 87.2, 80.7, 79.7, 79.3, 79.0, 78.9(2C), 78.576.4, 75.8, 74.4, 72.4, 72.1 ,71.3,70.2,66.4,63.6,62.9,62.5,57.8,54.7,50.1,48.5,44.7,44.4,4 2.7, 42.2, 41.1, 40.2, 38.9, 38.4, 29.0, 22.6, 20.9, 19.9, 16.1; HR-ESI-MS m / z calcd for C 43 H 72 NO 22 [M+NH4] + 954.4540, found 954.4556.

[0073] Compared to Example 2, which involves esterification of Yamaguchi at room temperature, Example 1, conducted at 0°C, achieves higher yields and HPLC purity. In Example 1, using compound 6a as the glycosyl donor, the overall yield of rebaudioside R reaches 52.6%. In Example 1, using compound 6b as the glycosyl donor, the overall yield of rebaudioside R reaches 50.9%. Therefore, the rebaudioside R synthesized by the method of this application has a higher yield than that of existing technologies.

[0074] The above embodiments mainly describe the basic principles, main features, and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The embodiments and descriptions in the specification are merely illustrative of the principles of the present invention. Various changes and modifications can be made to the present invention without departing from its spirit and scope, and all such changes and modifications fall within the scope of the present invention as claimed.

Claims

1. A method for synthesizing rabodiin R, characterized in that, Including the following steps: S1. In triethylamine, with DMAP as a catalyst, 2,4,6-trichlorobenzoyl chloride is added dropwise to esterify steviol with an organic acid, generating an esterification group PG1 at the C-13 position of steviol, to give compound 1. ; S2. Compound 1 and compound 2 are subjected to a nucleophilic reaction to obtain compound 3, wherein compound 2 is a pyranose with a halogenated C-OH1 position and the remaining C-OH positions protected by a hydroxyl protecting group PG2. ; S3. Under mild conditions, the esterification group PG1 at the C-13 position of compound 4 is hydrolyzed to obtain compound 4 with an in-situ hydroxyl group. ; S4, the hydroxyl group at the C-13 position of compound 4 is activated by a Lewis acid to form an oxonium ion, which undergoes a nucleophilic reaction with a glycosyl donor to give compound 5, wherein PG3 of compound 5 is a hydroxyl protecting group; ; S5. Remove all protecting groups from compound 5 to obtain the target product, bourediidine R. ; The hydroxyl protecting groups of compound 1 and the glycosyl donor are the same; compound 2 is a bromopyranose protected by an acetyl group; ; The glycosyl donor is compound 6. ; Compound 5 is: ; The R group of compound 6 is acetyl or 2,2-dimethyl-2-(o-nitrophenyl)acetyl.

2. The method for synthesizing rabodiin R as described in claim 1, characterized in that, In step S1, the organic acid is p-toluenesulfonic acid, and compound 1 is: 。 3. The method for synthesizing rabodiin R as described in claim 2, characterized in that, In step S1, the reaction temperature is from room temperature to 0°C, and the molar ratio of steviol, p-toluenesulfonic acid, triethylamine and DMAP is 1~1.05:1.25~1.5:3.05~3.2:1~1.

05.

4. The method for synthesizing retibandibrine R as described in claim 1, characterized in that, In step S2, compound 2 is a pyranose with a brominated C-1 position and acetyl groups protecting the remaining C-OH positions. 。 5. The method for synthesizing rabodiin R as described in claim 4, characterized in that, In step S2, compound 1 is dissolved in a solvent, and potassium carbonate and tetrabutylammonium bromide are added sequentially. After the addition is complete, the mixture is stirred at the same temperature. Then, compound 2 is added after stirring. The reaction temperature is from room temperature to 70°C. The molar ratio of compound 1, potassium carbonate, tetrabutylammonium bromide and compound 2 is 1~1.05; 3~3.05: 2~2.05: 2~2.

5.

6. The method for synthesizing retibandibrine R as described in claim 1, characterized in that, In step S3, compound 3 is dissolved in a solvent, and a base is added. The reaction temperature is 50 to 80°C. The molar ratio of compound 3 to base is 1:1.35 to 1.5, and the base is triethylamine or DBU.

7. The method for synthesizing rabodiin R as described in claim 1, characterized in that, In step S4, the reaction temperature is -40℃ to 0℃; the Lewis acid is one of TMSOTf, BF3·Et2O, or TBDMSOTf; the molar ratio of compound 4, Lewis acid, and compound 6 is 1~1.05:2~2.1:1~1.

05.

8. The method for synthesizing retibandibrine R as described in claim 1, characterized in that, In step S5, the deprotection reaction temperature is from 0°C to room temperature.

Citation Information

Patent Citations

  • Novel process method for preparing natural sweetening agent

    CN103159808A

  • High-purity steviol glycosides

    CN112512337A